Breast Scintigraphy

  • Ebrahim S. Delpassand
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA)


It was estimated that more than 180,000 new cases of breast cancer would be diagnosed among women in the United States during 1997 and that breast cancer would be responsible for 17% of women’s cancer deaths.1 Approximately one of every nine women develops breast cancer by age 85. The American Cancer Society recommends that women have their first screening mammogram by age 40, again every 1–2 years between the ages of 40 and 49, and yearly after age 50. In addition, a clinical physical examination of the breast is recommended every 3 years for women aged 20–40 and every year for those older than 40. The American Cancer Society also recommends monthly breast self-examination for women 20 years or older.


Breast Cancer Positron Emission Tomography Primary Breast Cancer Breast Lesion Nonpalpable Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1992;47(l):5–27.Google Scholar
  2. 2.
    Parker SH, Burbank F, Jackson RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994;193:359.PubMedGoogle Scholar
  3. 3.
    Sneige N. Fine needle aspiration of the breast: a review of 1995 cases with the emphasis on diagnostic pitfalls. Diagn Cytopathol 1993;9:106–112.PubMedCrossRefGoogle Scholar
  4. 4.
    Sneige N, Fornage BD, Saleh G. Ultrasound-guided fine needle aspiration of nonpalpable breast lesions. Am J Clin Pathol 1994;102:98–101.PubMedGoogle Scholar
  5. 5.
    Rosner D, Bedwani RN, Vana J, et al. Noninvasive breast carcinomas: results of a national survey by the American College of Surgeons. Ann Surg 1980;192:139–147.PubMedCrossRefGoogle Scholar
  6. 6.
    Rosner D, Lane WW, Penetrante R. Ductal carcinoma in situ with microinvasion: a curable entity using surgery alone without need for adjuvant therapy. Cancer 1991;67:1498–1503.PubMedCrossRefGoogle Scholar
  7. 7.
    Bland KI, Copeland EM III (eds). The Breast. Philadelphia: Saunders, 1991;318–326.Google Scholar
  8. 8.
    Piccolo S, Lastoria S, Mainolli C, et al. Technetium-99m methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 1995;36:718–725.PubMedGoogle Scholar
  9. 9.
    Burnett KR, Lyons KP, Theron-Brown W. Uptake of osteotropic radionuclides in the breast. Semin Nucl Med 1984;14:48–49.PubMedCrossRefGoogle Scholar
  10. 10.
    Uno K, Uchida Y, Sakata S, et al. Visualization of female breast in bone scintigraphy. Kaku Igaku 1992;29:1201–1206.PubMedGoogle Scholar
  11. 11.
    Waxman AD, Ramanna L, Mesmic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18–23.PubMedGoogle Scholar
  12. 12.
    Lee VW, Sax EJ, McAneny DB, et al. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993;34:2095–2100.PubMedGoogle Scholar
  13. 13.
    Schweil AM, McKillop JH, Milroy R, et al. Thallium-201 scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Commun 1990;11:263–269.CrossRefGoogle Scholar
  14. 14.
    Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: preliminary results and comparison with Tl-201. Clin Nucl Med 1992;17:171–176.PubMedCrossRefGoogle Scholar
  15. 15.
    Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491–497.PubMedGoogle Scholar
  16. 16.
    Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994;21:357–362.PubMedCrossRefGoogle Scholar
  17. 17.
    Kao CH, Wang SJ, Yeh SH. Technetium-99m MIBI uptake in breast carcinoma and axillary lymph node metastases. Clin Nucl Med 1994;19:898–900.PubMedCrossRefGoogle Scholar
  18. 18.
    Waxman A, Nagaraj N, Ashok G, et al. Sensitivity and specificity of Tc-99m methoxy isobutyle isonitrile (MIBI) in the evaluation of primary carcinoma of the breast: comparison of palpable and nonpalpable lesions with mammography [abstract]. J Nucl Med 1994;35:22P.Google Scholar
  19. 19.
    Nagaraj N, Waxman A, Ashok G, et al. Comparison of SPECT and planar Tc-99m sestamibi (MIBI) imaging in patients with carcinoma of the breast [abstract]. J Nucl Med 1994;35:229P.Google Scholar
  20. 20.
    Burak Z, Argon M, Memix A, et al. Evaluation of palpable breast masses with Tc-99m MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15:604–612.PubMedGoogle Scholar
  21. 21.
    Waxman AD, Ashok G, Kooba A, et al. The use of Tc-99m methoxy isobutyl isonitrile (MIBI) in evaluation of patients with primary carcinoma of the breast: comparison with Tl-201 (Tl) [abstract]. J Nucl Med 1993;34(suppl):139P.Google Scholar
  22. 22.
    Khalkhali I, Mena I, Jousnne E, et al. Technetium-99m sestamibi MIBI prone breast imaging in patients with suspicion of breast cancer [abstract]. J Nucl Med 1993;34(suppl):140P.Google Scholar
  23. 23.
    Taillefer R, Robidoux A, Lambert R, et al. Technetium-99m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758–1765.PubMedGoogle Scholar
  24. 24.
    Khalkhali I, Cutrone JA, Mena I, et al. Technetium-99m sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784–1789.PubMedGoogle Scholar
  25. 25.
    Palmedo H, Schomburg A, Grunwald F, et al. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626–630.PubMedGoogle Scholar
  26. 26.
    Khalkhali I, Villanueva-Meyer J, Edell SL, et al. Impact of breast density on the diagnostic accuracy of Tc-99m sestamibi breast imaging in the detection of breast cancer [abstract]. J Nucl Med 1996;37:74PGoogle Scholar
  27. 27.
    Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis (alkylisionitrile) technetium-99 complexes. J Nucl Med 1990;31:1166–1167.PubMedGoogle Scholar
  28. 28.
    Waxman A, Nagaraj N, Kovalevsky M, et al. Detection of primary breast malignancy with Tc-99m methoxyisobutylisonitrile (MIBI) in patients with non-palpable primary malignancies: the importance of lesion size [abstract]. J Nucl Med 1995;36:194.Google Scholar
  29. 29.
    Gupta P, Waxman A, Nguyen K, et al. Correlation of Tc-99m sestamibi uptake with histopathologic characteristics in patients with benign breast disease [abstract]. J Nucl Med 1996;1122:P250.Google Scholar
  30. 30.
    Waxman AD. The role of Tc-99m methoxisobutylisonitrile in imaging of breast cancer. Semin Nucl Med 1997;27:40–54.PubMedCrossRefGoogle Scholar
  31. 31.
    Carvalho PA, Chiu ML, Kranaug JF, et al. Subcellular distribution and analysis of Tc-99m MIBI in isolated perfused rat hearts. J Nucl Med 1992;33:1516–1521.PubMedGoogle Scholar
  32. 32.
    Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977–984.PubMedGoogle Scholar
  33. 33.
    Tse NY, Hoh CK, Hawkins RA, et al. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg 1992;216:27–34.PubMedCrossRefGoogle Scholar
  34. 34.
    Wahl RL, Cody RL, Hutchins GD, et al. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991;179:765–770.PubMedGoogle Scholar
  35. 35.
    Nabi HA, Seldin D, Barron B, et al. CEA-Scan radioimmunodetection of primary breast lesions: results of phase II multicenter trial [abstract]. Eur J Nucl Med 1995;22.Google Scholar
  36. 36.
    Nabi H, Rosner D, Erb D, et al. Evaluation of suspicious mammographic findings with CEA-Scan and correlation with histopathological results [abstract]. J Nucl Med 1996;238.Google Scholar
  37. 37.
    Maffioli L, Agresti R, Chita A, et al. Prone scintimammography in patients with non-palpable breast lesions [abstract]. Anticancer Res 1996;16:1269–1273.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1999

Authors and Affiliations

  • Ebrahim S. Delpassand

There are no affiliations available

Personalised recommendations